Related Experiment Video
Updated: Apr 19, 2026
07:34
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
1.4K
Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneity
Malte Krönig1, Max Walter1, Vanessa Drendel2
1Medical Center, University of Freiburg, Department of Urology, 79106 Freiburg, Germany.
Oncotarget
|December 17, 2014
Summary
This study introduces a novel method using functionalized gold nanoparticles and fluorescent activated flow cytometry (FACS) to identify and separate prostate tumor cells. This technique enables precise molecular profiling for improved prostate cancer prognosis.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Oncology
Background:
- Accurate identification and isolation of viable prostate tumor cells are crucial for advancing cancer research and improving prognostic accuracy.
- Heterogeneity in prostate tumor tissue necessitates multi-parameter molecular assays for precise characterization of tumor cells and their microenvironment.
Purpose of the Study:
- To develop and validate a novel technique for the specific identification, isolation, and analysis of living prostate tumor cells.
- To enable cell type-resolved gene expression profiling for enhanced prognostic accuracy in prostate cancer.
Main Methods:
- Utilized functionalized gold nanoparticles for fluorescence-based detection of absolute mRNA expression levels in living cells via fluorescent activated flow cytometry (FACS).
- Combined RNA and protein detection by FACS to gate specific cell populations: EPCAM+ tumor/benign cells, EPCAM/CD45- mesenchymal cells, and CD45+ lymphocytes.
- Sub-gated EPCAM+ epithelial cells into AMACR high and low expressing populations for detailed analysis.
Main Results:
- Successfully separated prostate tumor and benign cells from human prostate needle biopsies based on alpha-methylacyl-CoA racemase (AMACR) expression levels.
- Generated cell type-resolved gene expression profiles by analyzing 200 cells from distinct populations across multiple biopsies per patient.
- Demonstrated the feasibility of multiplexed gene expression profiling for detailed specimen characterization.
Conclusions:
- The developed technique provides a robust basis for the clinical evaluation of cell type-resolved gene expression profiles.
- This approach holds promise as a pre-therapeutic prognostic marker for prostate cancer, aiding in personalized treatment strategies.
- Advances in cell identification and molecular profiling can significantly improve the understanding and management of heterogeneous prostate tumors.
